ConductScience.org, home

Paper · 37101261

References168

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121048011LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection.J Clin Microbiol2011https://conductscience.org/library/papers/21048011PubMed
212657053Functional regulation of the Listeria monocytogenes bacteriophage A118 holin by an intragenic inhibitor lacking the first transmembrane domain.Mol Microbiol2003https://conductscience.org/library/papers/12657053PubMed
312499217Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains.Antimicrob Agents Chemother2003https://conductscience.org/library/papers/12499217PubMed
422439788Antistaphylococcal activity of bacteriophage derived chimeric protein P128.BMC Microbiol2012https://conductscience.org/library/papers/22439788PubMed
525733585A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae.J Antimicrob Chemother2015https://conductscience.org/library/papers/25733585PubMed
618471063Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis.J Infect Dis2008https://conductscience.org/library/papers/18471063PubMed
721535426Domain shuffling and module engineering of Listeria phage endolysins for enhanced lytic activity and binding affinity.Microb Biotechnol2011https://conductscience.org/library/papers/21535426PubMed
816565432Bacteriophage endolysins as a novel class of antibacterial agents.Exp Biol Med (Maywood)2006https://conductscience.org/library/papers/16565432PubMed
917827138
In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
J Antimicrob Chemother2007https://conductscience.org/library/papers/17827138PubMed
1014613958Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model.J Antimicrob Chemother2003https://conductscience.org/library/papers/14613958PubMed
1117186236Mutagenesis of a bacteriophage lytic enzyme PlyGBS significantly increases its antibacterial activity against group B streptococci.Appl Microbiol Biotechnol2007https://conductscience.org/library/papers/17186236PubMed
1230642930ClyJ Is a Novel Pneumococcal Chimeric Lysin with a Cysteine- and Histidine-Dependent Amidohydrolase/Peptidase Catalytic Domain.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/30642930PubMed
1327516758PL3 Amidase, a Tailor-made Lysin Constructed by Domain Shuffling with Potent Killing Activity against Pneumococci and Related Species.Front Microbiol2016https://conductscience.org/library/papers/27516758PubMed
1432291298Targeting Hidden Pathogens: Cell-Penetrating Enzybiotics Eradicate Intracellular Drug-Resistant Staphylococcus aureus.mBio2020https://conductscience.org/library/papers/32291298PubMed
1515231813Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium.J Bacteriol2004https://conductscience.org/library/papers/15231813PubMed
1630889831Phage Endolysins as Potential Antimicrobials against Multidrug Resistant Vibrio alginolyticus and Vibrio parahaemolyticus: Current Status of Research and Challenges Ahead.Microorganisms2019https://conductscience.org/library/papers/30889831PubMed
1727341401Pharmacokinetics of the phage endolysin-based candidate drug SAL200 in monkeys and its appropriate intravenous dosing period.Clin Exp Pharmacol Physiol2016https://conductscience.org/library/papers/27341401PubMed
1828860505Endolysin LysEF-P10 shows potential as an alternative treatment strategy for multidrug-resistant Enterococcus faecalis infections.Sci Rep2017https://conductscience.org/library/papers/28860505PubMed
1929776929Antibacterial Effects of Phage Lysin LysGH15 on Planktonic Cells and Biofilms of Diverse Staphylococci.Appl Environ Microbiol2018https://conductscience.org/library/papers/29776929PubMed
2015616283Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/15616283PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/37101261/references